AP2015008437A0 - Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception - Google Patents

Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception

Info

Publication number
AP2015008437A0
AP2015008437A0 AP2015008437A AP2015008437A AP2015008437A0 AP 2015008437 A0 AP2015008437 A0 AP 2015008437A0 AP 2015008437 A AP2015008437 A AP 2015008437A AP 2015008437 A AP2015008437 A AP 2015008437A AP 2015008437 A0 AP2015008437 A0 AP 2015008437A0
Authority
AP
ARIPO
Prior art keywords
pharmaceutical composition
composition containing
cox inhibitor
application regimen
containing levonorgestrel
Prior art date
Application number
AP2015008437A
Other languages
English (en)
Inventor
Ulrike Fuhrmann
Stefanie Lindemann
Peter Serno
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49585417&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2015008437(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of AP2015008437A0 publication Critical patent/AP2015008437A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AP2015008437A 2012-11-22 2013-11-19 Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception AP2015008437A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12193725 2012-11-22
EP13186133 2013-09-26
PCT/EP2013/074167 WO2014079840A1 (de) 2012-11-22 2013-11-19 Verwendung und anwendungsregime einer pharmazeutischen zusammensetzung enthaltend levonorgestrel und einen cox-inhibitor zur bedarfsweisen ("on-demand") kontrazeption

Publications (1)

Publication Number Publication Date
AP2015008437A0 true AP2015008437A0 (en) 2015-05-31

Family

ID=49585417

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2015008437A AP2015008437A0 (en) 2012-11-22 2013-11-19 Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception

Country Status (19)

Country Link
US (1) US9579330B2 (xx)
EP (1) EP2922552A1 (xx)
JP (1) JP6254605B2 (xx)
KR (1) KR20150085512A (xx)
CN (1) CN104797258A (xx)
AP (1) AP2015008437A0 (xx)
AU (1) AU2013349776A1 (xx)
BR (1) BR112015011212A2 (xx)
CA (1) CA2891854A1 (xx)
CL (1) CL2015001368A1 (xx)
EA (1) EA201590903A1 (xx)
HK (1) HK1207588A1 (xx)
IL (1) IL238767A0 (xx)
MX (1) MX2015006499A (xx)
PH (1) PH12015501110A1 (xx)
SG (1) SG11201503275RA (xx)
TN (1) TN2015000197A1 (xx)
TW (1) TW201420103A (xx)
WO (1) WO2014079840A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3178476A1 (de) 2009-06-23 2017-06-14 Bayer Intellectual Property GmbH Pharmazeutische zusammensetzung und behandlungsverfahren zur notfallempfängnisverhütung
WO2022225986A1 (en) * 2021-04-19 2022-10-27 Archer David Fitzgerald On demand female contraceptive

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4576063A (en) 1982-02-27 1986-03-18 Toyota Jidosha Kabushiki Kaisha Transmission mechanism with parallel transmission systems including one way clutches, one being lockable
EP0520119A1 (de) 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Neue orale Diclofenaczubereitung
IL123813A0 (en) 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
HU227198B1 (en) 2001-11-27 2010-10-28 Richter Gedeon Nyrt Pharmaceutical composition for emergency contraception containing levonorgestrel
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
DE102005050729A1 (de) 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
CA2757496A1 (en) * 2009-04-14 2010-10-21 Andre Ulmann Method for on-demand contraception
EP2419109B1 (en) * 2009-04-14 2016-04-13 Laboratoire HRA-Pharma Method for on-demand contraception using levonorgestrel or norgestrel
EP3178476A1 (de) * 2009-06-23 2017-06-14 Bayer Intellectual Property GmbH Pharmazeutische zusammensetzung und behandlungsverfahren zur notfallempfängnisverhütung

Also Published As

Publication number Publication date
WO2014079840A1 (de) 2014-05-30
TN2015000197A1 (en) 2016-10-03
US9579330B2 (en) 2017-02-28
AU2013349776A1 (en) 2015-05-28
CA2891854A1 (en) 2014-05-30
JP6254605B2 (ja) 2017-12-27
EP2922552A1 (de) 2015-09-30
KR20150085512A (ko) 2015-07-23
US20160000805A1 (en) 2016-01-07
TW201420103A (zh) 2014-06-01
JP2016500087A (ja) 2016-01-07
BR112015011212A2 (pt) 2017-07-11
CL2015001368A1 (es) 2015-07-24
CN104797258A (zh) 2015-07-22
EA201590903A1 (ru) 2015-11-30
IL238767A0 (en) 2015-06-30
SG11201503275RA (en) 2015-06-29
MX2015006499A (es) 2015-08-14
HK1207588A1 (en) 2016-02-05
PH12015501110A1 (en) 2015-08-10

Similar Documents

Publication Publication Date Title
HUS2200018I1 (hu) Drospirenont tartalmazó gyógyszerkészítmény, fogamzásgátlóként történõ alkalmazásra
IL240290A0 (en) History of pyridazinone-amide and pharmaceutical preparations containing them
IL222738A0 (en) Pharmaceutical emulsion composition comprising progestogen
EP2542074A4 (en) PHARMACEUTICAL COMBINATION ACTIVE AGENTS AS HCV REPLICATION INHIBITORS
PT3043773T (pt) Composição farmacêutica de dose fixa estável composta por mometasona e olopatadina para administração nasal
IL234884A0 (en) Inhibitors of kynurenine-3-monooxygenase pharmaceutical compositions, and methods of their use
HUE040093T2 (hu) Ibuprofén és tramadol gyógyászati kompozíciója szemgyógyászati alkalmazásra
IL237322A0 (en) Solid pharmaceutical preparations containing levothyroxine and their preparation
EP2968698A4 (en) COMPOUNDS AND COMPOSITIONS FOR RELEASE OF MEDICAMENT
GB2504390B (en) Nutraceutical and pharmaceutical composition
IL235947A0 (en) History of isonicotinamide in solid state and pharmaceutical preparations containing them
HK1207588A1 (en) Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception cox
RS58752B1 (sr) Farmaceutska kompozicija sa produženim oslobađanjem trimetazidina
HK1213977A1 (zh) 含雙氯芬酸和硫代秋水仙碱苷的穩定的可注射組合物
HUP1600414A2 (hu) Bisoprololt és ramiprilt tartalmazó stabil kombinációs gyógyszerkészítmény
HK1217640A1 (zh) 藥物組合物及其用途以及所述藥物組合物用於按需避孕的施用方法
EP2857016A4 (en) INJECTABLE PHARMACEUTICAL COMPOSITION OF DEXKETOPROFEN AND TRAMADOL
RS59631B1 (sr) Farmaceutska formulacija koja sadrži kurkumin
IL233983A0 (en) History of thiazolidinones, their preparation and pharmaceutical preparations containing them
HK1206273A1 (en) Pharmaceutical composition of a papillomavirus inhibitor
ZA201503799B (en) Fixed dose pharmaceutical composition comprising mometasone and azelastine
EP3195864A4 (en) Pharmaceutical composition containing an analgesic agent and an antispasmosdic agent
EP2844067A4 (en) ORAL TABLET FORMULATION OF ROSUV ASTATIN WITH IMMEDIATE RELEASE AND METOMETINE WITH DELAYED RELEASE